Resistance to antiretroviral drugs remains an important limitation to successful human
immunodeficiency virus type 1 (HIV-1) therapy. Resistance testing can improve treatment …

A substantial number of studies have been performed across the world to determine
transmitted drug resistance. Large variations between different parts of the world can be …

Following interruption of antiretroviral therapy among individuals with acquired drug
resistance, preexisting drug-sensitive virus emerges relatively rapidly. In contrast, wild-type …

Genetic diversity plays a key role in human immunodeficiency virus (HIV) adaptation,
providing a mechanism to escape host immune responses and develop resistance to …

Objectives: Representative prevalence data of transmitted drug-resistant HIV-1 are essential
to establish accurate guidelines addressing resistance testing and first-line treatments …

Shortly after AIDS was recognized in USA, the first cases were diagnosed in Denmark. 1, 2
Today Denmark has a population of 5.3 million citizens and the prevalence of HIV infection …

Background: The transmission of drug-resistant HIV-1 can impair the virological response to
antiretroviral therapy. Minority-resistant variants have been detected in acute …

Background Drug resistance monitoring of the paediatric HIV-1-infected population is
required to optimize treatment success and preserve future treatment options. Objectives To …

Background: Transmission of drug-resistant HIV strains to antiretroviral therapy (ART)-naïve
subjects can negatively impact therapy response. As treatment strategies and utilization of …

Background: Transmission of drug-resistant variants is influenced by several factors,
including the HIV-1 RNA levels in HIV-1-infected patients. Our study describes the …